Real-time Estimate Cboe BZX Other stock markets | 5-day change | 1st Jan Change | ||
15.39 USD | +3.36% | | -3.04% | -40.77% |
May. 29 | Nvidia soon to join the Dow Jones? | ![]() |
May. 23 | Health Care Limits Losses Amid Defensive Bias - Health Care Roundup | DJ |
Valuation
Fiscal Period: August | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 46,232 | 32,946 | 43,898 | 30,301 | 21,849 | 12,846 | - | - |
Enterprise Value (EV) 1 | 62,045 | 48,668 | 51,685 | 39,503 | 30,172 | 20,019 | 19,623 | 18,789 |
P/E ratio | 11.9x | 73.1x | 17.3x | 7x | -7.09x | -1.78x | 7.56x | 6.38x |
Yield | 3.47% | 4.92% | 3.7% | 5.45% | - | 9.49% | 6.97% | 8.51% |
Capitalization / Revenue | 0.34x | 0.24x | 0.33x | 0.23x | 0.16x | 0.09x | 0.09x | 0.08x |
EV / Revenue | 0.45x | 0.35x | 0.39x | 0.3x | 0.22x | 0.14x | 0.13x | 0.12x |
EV / EBITDA | 7.37x | 6.82x | 7.87x | 6.3x | 6.03x | 4.08x | 3.73x | 3.08x |
EV / FCF | 15.9x | 11.8x | 12.4x | 18.2x | 214x | 14.4x | 8.89x | 7.11x |
FCF Yield | 6.27% | 8.45% | 8.08% | 5.48% | 0.47% | 6.94% | 11.2% | 14.1% |
Price to Book | 1.95x | 1.59x | 1.84x | 1.03x | 0.77x | 0.87x | 0.83x | 0.73x |
Nbr of stocks (in thousands) | 903,143 | 866,534 | 864,987 | 864,257 | 863,261 | 862,713 | - | - |
Reference price 2 | 51.19 | 38.02 | 50.75 | 35.06 | 25.31 | 14.89 | 14.89 | 14.89 |
Announcement Date | 10/28/19 | 10/15/20 | 10/14/21 | 10/13/22 | 10/12/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: August | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 136,866 | 139,537 | 132,509 | 132,703 | 139,081 | 145,306 | 150,788 | 157,141 |
EBITDA 1 | 8,413 | 7,138 | 6,567 | 6,268 | 5,002 | 4,906 | 5,259 | 6,100 |
EBIT 1 | 6,942 | 5,211 | 5,117 | 5,133 | 3,871 | 3,051 | 3,512 | 3,947 |
Operating Margin | 5.07% | 3.73% | 3.86% | 3.87% | 2.78% | 2.1% | 2.33% | 2.51% |
Earnings before Tax (EBT) 1 | 4,527 | 743 | 1,995 | 3,985 | -5,419 | -12,945 | 1,529 | 1,333 |
Net income 1 | 3,982 | 456 | 2,542 | 4,337 | -3,080 | -7,176 | 1,806 | 2,163 |
Net margin | 2.91% | 0.33% | 1.92% | 3.27% | -2.21% | -4.94% | 1.2% | 1.38% |
EPS 2 | 4.310 | 0.5200 | 2.930 | 5.010 | -3.570 | -8.371 | 1.969 | 2.335 |
Free Cash Flow 1 | 3,892 | 4,111 | 4,176 | 2,165 | 141 | 1,389 | 2,207 | 2,643 |
FCF margin | 2.84% | 2.95% | 3.15% | 1.63% | 0.1% | 0.96% | 1.46% | 1.68% |
FCF Conversion (EBITDA) | 46.26% | 57.59% | 63.59% | 34.54% | 2.82% | 28.31% | 41.97% | 43.32% |
FCF Conversion (Net income) | 97.74% | 901.54% | 164.28% | 49.92% | - | - | 122.22% | 122.21% |
Dividend per Share 2 | 1.778 | 1.870 | 1.880 | 1.912 | - | 1.414 | 1.038 | 1.267 |
Announcement Date | 10/28/19 | 10/15/20 | 10/14/21 | 10/13/22 | 10/12/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: August | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 33,901 | 33,756 | 32,597 | 32,449 | 33,382 | 34,862 | 35,415 | 35,422 | 36,707 | 37,052 | 35,967 | 36,066 | 37,764 | 37,899 | 37,589 |
EBITDA 1 | 2,277 | 1,931 | 1,232 | 993 | 1,510 | 1,774 | 1,556 | 1,013 | 1,028 | 1,244 | 1,147 | 1,131 | 1,362 | 1,474 | 1,346 |
EBIT 1 | 1,777 | 1,657 | 955 | 744 | 1,014 | 1,215 | 959 | 683 | 687 | 900 | 740.6 | 726.2 | 836.8 | 1,037 | 943.3 |
Operating Margin | 5.24% | 4.91% | 2.93% | 2.29% | 3.04% | 3.49% | 2.71% | 1.93% | 1.87% | 2.43% | 2.06% | 2.01% | 2.22% | 2.74% | 2.51% |
Earnings before Tax (EBT) 1 | 3,814 | 947 | -18 | -758 | -5,270 | 607 | -382 | -375 | -358 | -13,114 | 321.5 | 264.8 | 438.2 | 579.2 | 542.7 |
Net income 1 | 3,580 | 883 | 289 | -415 | -3,721 | 703 | 118 | -180 | -67 | -5,908 | 233.3 | 236.2 | 361.3 | 507.9 | 457 |
Net margin | 10.56% | 2.62% | 0.89% | -1.28% | -11.15% | 2.02% | 0.33% | -0.51% | -0.18% | -15.95% | 0.65% | 0.66% | 0.96% | 1.34% | 1.22% |
EPS 2 | 4.130 | 1.020 | 0.3300 | -0.4800 | -4.310 | 0.8100 | 0.1400 | -0.2100 | -0.0800 | -6.850 | 0.2333 | 0.2455 | 0.3820 | 0.5579 | 0.4961 |
Dividend per Share 2 | 0.4775 | 0.4775 | 0.4775 | 0.4800 | 0.4800 | - | 0.4800 | - | 0.2500 | 0.2500 | 0.2500 | 0.2500 | 0.2500 | 0.3638 | 0.2500 |
Announcement Date | 1/6/22 | 3/31/22 | 6/30/22 | 10/13/22 | 1/5/23 | 3/28/23 | 6/27/23 | 10/12/23 | 1/4/24 | 3/28/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
Fiscal Period: August | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 15,813 | 15,722 | 7,787 | 9,202 | 8,323 | 7,173 | 6,777 | 5,943 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.88x | 2.203x | 1.186x | 1.468x | 1.664x | 1.462x | 1.289x | 0.9743x |
Free Cash Flow 1 | 3,892 | 4,111 | 4,176 | 2,165 | 141 | 1,389 | 2,207 | 2,643 |
ROE (net income / shareholders' equity) | 22.3% | 18.9% | 20.5% | 16.4% | 11.9% | 13.7% | 18.6% | 19.2% |
ROA (Net income/ Total Assets) | 5.87% | 0.59% | 5.46% | 5.06% | 3.68% | -9.79% | 2.02% | 2.6% |
Assets 1 | 67,861 | 77,380 | 46,566 | 85,705 | -83,627 | 73,278 | 89,445 | 83,174 |
Book Value Per Share 2 | 26.30 | 23.80 | 27.50 | 34.00 | 32.80 | 17.10 | 18.00 | 20.40 |
Cash Flow per Share 2 | 6.060 | 6.230 | 6.410 | 4.500 | 2.620 | 4.320 | 4.460 | 4.490 |
Capex 1 | 1,702 | 1,374 | 1,379 | 1,734 | 2,117 | 1,543 | 1,610 | 1,681 |
Capex / Sales | 1.24% | 0.98% | 1.04% | 1.31% | 1.52% | 1.06% | 1.07% | 1.07% |
Announcement Date | 10/28/19 | 10/15/20 | 10/14/21 | 10/13/22 | 10/12/23 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Ratings for Walgreens Boots Alliance, Inc.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
14.89USD
Average target price
22.77USD
Spread / Average Target
+52.93%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
Sector Other Drug Retailers
1st Jan change | Capi. | |
---|---|---|
WALGREENS BOOTS ALLIANCE, INC. | -42.91% | 12.85B |
JD HEALTH INTERNATIONAL INC. | -31.07% | 11.12B |
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | -15.33% | 7.31B |
YIFENG PHARMACY CHAIN CO., LTD. | +14.51% | 6.39B |
-13.20% | 5.68B | |
CORPORATIVO FRAGUA, S.A.B. DE C.V. | +73.90% | 4.95B |
NAHDI MEDICAL COMPANY | -3.36% | 4.63B |
CLICKS GROUP LIMITED | -6.07% | 3.96B |
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. | -18.76% | 3.18B |
WELCIA HOLDINGS CO., LTD. | -13.46% | 2.79B |
Other Drug Retailers
- Stock Market
- Equities
- WBA Stock
- Financials Walgreens Boots Alliance, Inc.